We here report a rare salivary gland tumor, a non-sebaceous lymphadenoma (NSLA), in the parotid gland with positive technetium-99m (99mTc) pertechnetate scintigraphy and cervical masses that was difficult to distinguish from malignant lymphoma preoperatively. A 65-year-old Japanese woman presented to our institution with a painless left parotid mass that had been gradually enlarging for three months. Computed tomography and magnetic resonance imaging showed a solid mass (30 mm) in the tail of the left parotid gland with three swellings (each 10 mm) on the periphery of the parotid gland. A low grade malignant lymphoma was diagnosed by fine needle aspiration cytology. Gallium-67 scintigraphy showed mild positivity. On 99mTc pertechnetate scintigraphy, the mild accumulation remained after oral stimulation with a mixture of ascorbic acid and calcium pantothenate. The patient underwent superficial parotidectomy with removal of the cervical masses. Our findings in this patient suggest that 99mTc positivity may constitute a clue to the preoperative diagnosis of NSLA that has pathologically overlapping sites with Warthin tumor.
Introduction
Non-sebaceous lymphadenoma (NSLA), a rare benign salivary gland tumor, is included in the World Health Organization's classification of 2005 (1) . These tumors are a type of lymphadenoma with intermingled lymphoid and epithelial components that lack sebaceous differentiation. Only 47 cases have been reported in English literature (2) (3) (4) (5) (6) . NSLA most commonly arises within the parotid gland (39 cases, 83%), with rare reports of origination in the minor salivary glands of the lips or submandibular glands. It characteristically grows slowly over many years. Recurrence, malignant transformation, and metastasis to multiple organs have not been reported. It is difficult for clinicians or pathologists to make the diagnosis preoperatively. Moreover, most published reports have focused on the pathological characteristics. Thus, otorhinolaryngologists may not be familiar with its clinical features.
We here report an NSLA of the parotid gland with positive technetium-99m (99mTc) pertechnetate scintigraphy and cervical masses that was difficult to distinguish from malignant lymphoma preoperatively. To the best of our knowledge, this is the first report of NSLA examined by 99mTc pertechnetate scintigraphy and with cervical lymphadenopathy.
Case Presentation
A 65-year-old Japanese woman was referred to our clinic with a painless left parotid mass that had been growing slowly for three months. She had had primary biliary cholangitis for eight years and sometimes had mild liver dysfunction. She had not lost weight or had night sweats in the previous few months. Physical examination revealed a 30×20 mm mobile mass of elastic to hard consistency inferior to the left ear. There was no significant cervical, axillary, or inguinal lymphadenopathy, and no facial nerve dysfunction. As to blood tests, her liver function was normal, and sIL-2R was negative. Computed tomography (CT) of the head and neck showed a well-demarcated enhancing solid mass (35×34×13 mm) in the tail of the left parotid gland Turkish Archives of Otorhinolaryngology (Figure 1 ). Magnetic resonance imaging (MRI) of the head and neck revealed a well-defined, gadolinium-enhancing solid mass with hypointensity on T1-weighted and hyperintensity on T2-weighted images ( Figure 2 ). There was no invasion of the surrounding tissues and the three nodules were identified around the parotid gland. Fine needle aspiration cytology (FNAC) revealed many small to medium lymphocytes, a few large lymphocytes with mild nuclear atypia and increased chromatin and a few tingible body macrophages. The lesion was Class III according to the Papanicolaou classification. It was difficult to distinguish between inflammatory changes and low grade lymphoma on FNAC.
To further determine the diagnosis, two scintigraphic examinations were performed. On gallium-67 (Ga67) scintigraphy, there was mild accumulation in the lesion in the left parotid gland. On 99mTc pertechnetate scintigraphy, there was accumulation in either parotid and submandibular glands. Mild accumulation remained in the left parotid gland after oral stimulation with a mixture of ascorbic acid and calcium pantothenate (Figure 3 ). Thus, a benign parotid gland tumor such as Warthin tumor or pleomorphic adenoma was suspected preoperatively. However, the presence of cervical nodules adjacent to the left parotid gland meant that malignant lymphoma could not be excluded.
The patient underwent superficial parotidectomy with removal of the cervical masses to establish a definite diagnosis and as treatment. None of the cervical masses were adherent to the surrounding tissues. A partial parotidectomy was performed, the operative specimen being 4.5×3.5×1.0 cm. Microscopically, the tumor was encapsulated by fibrous tissue with clear borders between it and the unaffected salivary gland. Tubuloglandular structures and many lymphocytes, some of which were forming reactive lymph follicles with germinal centers, were observed in the tumor (Figure 4) . The epithelial and lymphoid components were not carcinomatous or lymphomatous, respectively. No metastases were found in the excised lymph nodes. The final pathological diagnosis was lymphadenoma, non-sebaceous type. The patient had no adverse events and was discharged in a stable condition. No recurrence was detected during 54 months of follow-up. Informed consent for publication was obtained from the patient.
Discussion
We here present a case of a rare lesion, NSLA, that originated in the parotid gland, was positive on 99mTc pertechnetate scintigraphy, and was associated with surrounding reactive lymph nodes. To the best of our knowledge, these lesions have never been diagnosed as NSLA preoperatively by FNAC. Thus, our finding of 99mTc pertechnetate scintigraphy positivity after oral stimulation is expected to help clinicians to diagnose NSLA preoperatively and to distinguish NSLA from other parotid gland tumors.
It is very difficult for otolaryngologists or pathologists to diagnose NSLA preoperatively. A definite preoperative diagnosis based on FNAC findings has never been reported (2-6). It may be impossible to diagnose a NSLA without examining the whole tumor.
The finding that 99mTc scintigraphy after oral stimulation was weakly positive in this case is interesting. No other articles has described the relationship between NSLA and 99mTc scintigraphy. 99mTc scintigraphy positivity in the parotid gland suggests a tumor, specifically Warthin tumor because it does not communicate with the salivary ductal system, the accumulated 99mTc scintigraphy remains in the gland without being secreted. The reason that this case presented 99mTc pertechnetate positive could be that lymphadenoma and Warthin tumor have pathologically overlapping sites (7). 99mTc scintigraphy may aid in preoperative diagnosis of NSLA and should be performed in future cases.
We present a rare case of NSLA in the parotid gland with surrounding lymphadenopathy. This combination is rare. The pathology responsible for the lymphadenopathy is uncertain, the most likely possibility being a nonspecific reaction to the parotid gland tumor, this being consistent with the location of the lymphadenopathy and its pathological features. However, cervical lymphadenopathy with a benign parotid gland tumor is unusual. The NSLA may have stimulated the chronic inflammation associated with our patient's primary biliary cholangitis (8) . Future reports of this rare combination are needed.
Conclusion
We present a rare case of NSLA in the parotid gland with positive 99mTc pertechnetate scintigraphy and cervical lymphadenopathy. We consider that 99mTc pertechnetate positivity may be useful for making a preoperative diagnosis of NSLA.
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